Editorial: Sulphasalazine-induced lung disease.
D000328:Adult; D001835:Body Weight; D003093:Colitis, Ulcerative / Q000150:complications / Q000188:drug therapy; D003371:Cough / Q000139:chemically induced; D004417:Dyspnea / Q000139:chemically induced; D004802:Eosinophilia / Q000139:chemically induced; D005260:Female; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology; D008168:Lung / Q000503:physiopathology; D008171:Lung Diseases / Q000139:chemically induced* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011658:Pulmonary Fibrosis / Q000139:chemically induced; D012460:Sulfasalazine / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D013997:Time Factors; D014797:Vital Capacity
D012460:Sulfasalazine